TABLE 1.

Analysis of PEL lines

Cell line	Reference	p53 status	DOX IC50 (ng/ml)	Tumor take (%)
BC-3	2	WT/WTe	7.48	3/3 (100)
VG-1	7	WT/WT	14.9	7/10 (70)
BCLM	29	WT/WT	5.56	4/5 (80)
JSC-1	10	WT/WT	18.0	1/5 (20)
BC-1	12	WT/WTa	4.52	10/10 (100)
BCBL-1	42	WT/M246Ib	31.2	6/7 (86)c
BCP-1	5	S262/S262 Ins	>75.0	6/6 (100)d

^aPreviously reported by Chadburn et al. (14).

^bPreviously reported by Katano et al. (38).

^cPreviously reported by Staudt et al. (65).

^dPreviously reported by Boshoff et al. (5).

^eWT, wild type.